Europe Respiratory Care Devices Market Size, Share, Growth, Trends & Forecast 2026–2034

Europe Respiratory Care Devices Market Overview

The Europe Respiratory Care Devices Market is projected to grow from US$ 6.22 billion in 2025 to US$ 11.88 billion by 2034, registering a compound annual growth rate (CAGR) of 7.45% during 2026–2034. Market growth is driven by the rising prevalence of chronic respiratory diseases, an aging population, increasing demand for home healthcare, and continuous technological advancements in respiratory treatment and monitoring equipment.

Respiratory care devices play an essential role in diagnosing, monitoring, and treating conditions such as chronic obstructive pulmonary disease (COPD), asthma, obstructive sleep apnea, pneumonia, and respiratory distress syndrome. Hospitals, intensive care units, clinics, and home healthcare providers rely on ventilators, oxygen concentrators, nebulizers, CPAP and BiPAP machines, pulse oximeters, and respiratory monitoring systems to improve patient care.

The growing adoption of portable equipment, connected monitoring technologies, and non-invasive respiratory support solutions is creating additional opportunities for manufacturers. Germany, the United Kingdom, France, Italy, and Spain remain important markets because of their healthcare infrastructure, established treatment networks, and substantial patient populations.

What Are Respiratory Care Devices?

Respiratory care devices are medical technologies used to support breathing, deliver respiratory medication, measure lung function, monitor oxygen levels, and manage acute or chronic respiratory disorders. They range from diagnostic equipment, including spirometers, to therapeutic technologies such as mechanical ventilators and oxygen concentrators.

These devices are used in hospitals, emergency departments, rehabilitation centers, outpatient facilities, and residential healthcare environments. Their increasing availability supports earlier diagnosis, continuous disease management, and treatment outside traditional clinical settings.

Demand across Europe is particularly important because chronic respiratory diseases affect approximately 81.7 million people across the WHO European Region. Meanwhile, people aged 65 and above accounted for approximately 22% of the European Union population in 2025, increasing the need for long-term respiratory treatment and monitoring.

Key Market Highlights

• Market size: US$ 6.22 billion in 2025.
• Forecast market size: US$ 11.88 billion by 2034.
• Forecast CAGR: 7.45% during 2026–2034.
• Major growth drivers: Chronic respiratory diseases, population aging, technological innovation, and home healthcare adoption.
• Key device categories: Therapeutic devices, monitoring devices, diagnostic devices, and consumables and accessories.
• Major applications: COPD, asthma, obstructive sleep apnea, respiratory distress syndrome, and cystic fibrosis.
• Leading end-user category: Hospitals, supported by intensive care requirements and demand for advanced respiratory equipment.
• Important markets: Germany, the United Kingdom, France, Italy, and Spain.

Growth Drivers of the Europe Respiratory Care Devices Market

1. Rising Prevalence of Chronic Respiratory Diseases

The growing burden of respiratory illnesses is a primary driver of market expansion. COPD, asthma, respiratory infections, and other pulmonary conditions frequently require continuous monitoring, medication delivery, oxygen therapy, or mechanical breathing support.

According to the WHO, chronic respiratory diseases affect approximately 81.7 million people across its European Region. COPD accounts for a substantial proportion of respiratory disease-related deaths, creating sustained demand for oxygen concentrators, ventilators, nebulizers, and non-invasive ventilation systems.

Environmental pollution, tobacco use, occupational exposure, and other risk factors contribute to respiratory disease incidence. As healthcare systems prioritize early diagnosis and long-term disease management, demand for reliable respiratory technologies is expected to increase.

2. Aging Population and Increasing Healthcare Requirements

Europe’s aging population is creating a larger market for respiratory care equipment. Older adults are more susceptible to COPD, pneumonia, sleep-related breathing disorders, and other conditions that may require ongoing treatment.

The EU population aged 65 and above represented approximately 22% of the total population in 2025. This demographic trend is increasing demand for portable oxygen systems, CPAP and BiPAP machines, respiratory monitors, and home ventilation equipment.

Manufacturers are responding with lightweight, user-friendly, and digitally connected devices designed to support elderly patients and caregivers. Improved usability and remote monitoring capabilities can also help healthcare professionals manage chronic respiratory conditions more efficiently.

3. Technological Advancements and Home Healthcare Expansion

Technological innovation is transforming respiratory care across Europe. Connected devices, remote monitoring platforms, portable oxygen concentrators, smart inhalers, and advanced ventilators are enabling more flexible treatment and patient management.

Home healthcare is particularly important for patients requiring long-term oxygen therapy, sleep apnea treatment, or respiratory support. Portable equipment can improve mobility and convenience, while connected platforms allow clinicians to review therapy data and identify potential adherence issues.

These developments support the transition toward decentralized healthcare and create opportunities for companies offering integrated respiratory treatment and monitoring solutions.

4. Increasing Awareness of Sleep Apnea and Asthma

Greater awareness of sleep-related breathing disorders and asthma is supporting demand for specialized respiratory devices. Obstructive sleep apnea can cause repeated interruptions in breathing during sleep, while asthma can produce wheezing, coughing, and breathlessness.

CPAP and BiPAP machines, inhalers, nebulizers, peak-flow meters, and diagnostic monitoring systems play important roles in managing these conditions.

Connected respiratory technologies, including digital inhaler solutions such as Aptar Pharma’s HeroTracker Sense, introduced in February 2024, illustrate the growing emphasis on treatment adherence and digital disease management.

Challenges in the Europe Respiratory Care Devices Market

High Costs of Advanced Equipment

Advanced ventilators, portable oxygen concentrators, and connected monitoring systems can involve substantial purchase, maintenance, and replacement costs. Differences in reimbursement policies and healthcare budgets across European countries may affect access to newer technologies.

Manufacturers must demonstrate clinical value, reliability, affordability, and compatibility with healthcare procurement requirements to encourage wider adoption.

Underdiagnosis and Limited Diagnostic Capacity

Underdiagnosis of respiratory diseases can delay treatment and reduce the number of patients receiving appropriate respiratory support. Limited access to spirometry, delayed referrals, and gaps in professional training remain challenges in some healthcare settings.

Expanding pulmonary diagnostic services, improving primary-care screening, and increasing awareness of respiratory symptoms could help address these barriers and support the adoption of respiratory care devices.

Europe Respiratory Care Devices Market Trends

Growing Demand for Therapeutic Devices

Therapeutic equipment represents a major component of the market because it directly supports breathing and respiratory disease treatment. Market estimates indicate that therapeutic devices accounted for approximately 55.6% of the European market in 2025.

Mechanical ventilators, oxygen therapy equipment, nebulizers, and CPAP/BiPAP systems are used in hospitals and home healthcare settings. Demand is supported by chronic respiratory diseases, critical-care requirements, and long-term treatment needs.

Expansion of Respiratory Consumables and Accessories

Respiratory masks, breathing circuits, tubes, filters, and other accessories generate recurring demand because many components require periodic replacement. Hospitals and home-care providers purchase these products to maintain hygiene, safety, and equipment performance.

The expanding installed base of ventilators, CPAP machines, and oxygen therapy systems is supporting the recurring consumables business.

Increasing Adoption of Connected Respiratory Care

Remote monitoring and digital connectivity are becoming increasingly important in respiratory treatment. Connected systems can help healthcare professionals evaluate treatment adherence, monitor selected patient parameters, and support follow-up care.

These technologies are particularly relevant for chronic respiratory conditions requiring regular monitoring and long-term therapy.

Respiratory Care Device Launches and Developments in Europe

Product innovation is improving patient comfort, ventilation capabilities, and remote treatment management.

• RESPINOR DXT (2025): RESPINOR announced CE marking under the EU Medical Device Regulation in August 2025 for its non-invasive diaphragm monitoring technology, designed to support respiratory muscle monitoring in intensive care.
• Prisma SMART Max (2024): Löwenstein Medical’s CPAP platform supports sleep apnea treatment with pressure regulation and patient-focused features.
• AirTouch N30i (2024): ResMed introduced a fabric-wrapped nasal CPAP mask designed to improve comfort and moisture management.
• AirFit F40 (2024): ResMed’s compact full-face CPAP mask focuses on flexibility, comfort, and ease of movement during sleep therapy.
• AirView remote monitoring: ResMed’s connected-care platform supports remote review of respiratory therapy information, including CPAP adherence data, where available.

These developments reflect the industry’s emphasis on patient comfort, digital healthcare, and more personalized respiratory treatment. Product availability, indications, and regulatory status should be verified for each country before publication.

Segment Analysis of the Europe Respiratory Care Devices Market

By Device Type

• Therapeutic devices
• Monitoring devices
• Diagnostic devices
• Consumables and accessories

Therapeutic devices are a major revenue category, while monitoring and diagnostic equipment supports early detection, treatment evaluation, and ongoing patient management.

By Product Type

• Respiratory consumables
• Nebulizers
• Oxygen concentrators
• Polysomnography devices
• Pulse oximeters
• Mechanical ventilators
• Spirometers
• Other respiratory care products

By Application

• Chronic obstructive pulmonary disease (COPD)
• Obstructive sleep apnea
• Asthma
• Respiratory distress syndrome
• Cystic fibrosis
• Other respiratory conditions

COPD and asthma create significant demand for long-term respiratory management, while sleep apnea supports the use of CPAP systems and sleep diagnostic technologies.

By End User

• Hospitals
• Home care
• Ambulatory care

Hospitals remain a major end-user segment because they require ventilators, advanced monitoring systems, oxygen therapy equipment, and respiratory consumables for critical and acute care. Meanwhile, home healthcare is benefiting from portable devices and remote monitoring solutions.

Country Analysis: Europe Respiratory Care Devices Market

Germany

Germany benefits from an advanced healthcare infrastructure, an established medical technology industry, and significant demand for respiratory treatment. An aging population and the burden of COPD, pneumonia, and sleep-related breathing disorders support demand for ventilators, oxygen concentrators, and connected respiratory equipment.

United Kingdom

The UK market is supported by demand from the NHS, respiratory disease management programs, and expanding home healthcare services. COPD, asthma, and respiratory infections create requirements for diagnostic devices, inhalation systems, oxygen therapy equipment, and respiratory monitoring technologies.

France

France represents an important market due to its established healthcare infrastructure and substantial asthma patient population. Demand for inhalers, nebulizers, peak-flow meters, CPAP systems, and respiratory monitoring solutions is supported by preventive healthcare and chronic disease management.

Italy

Italy’s aging population is an important driver of respiratory care demand. Oxygen concentrators, nebulizers, ventilators, and CPAP systems support the management of chronic respiratory conditions, particularly among older adults. Home healthcare and remote monitoring are additional areas of opportunity.

Spain and Other European Countries

Spain, Belgium, the Netherlands, Poland, Norway, Portugal, Greece, Romania, Russia, and other European markets contribute to regional demand. Market development varies according to disease prevalence, healthcare spending, reimbursement arrangements, access to diagnostics, and the adoption of advanced medical technologies.

Competitive Landscape and Major Companies

The Europe respiratory care devices market includes multinational medical technology companies and specialized respiratory equipment manufacturers.

Key companies covered in the market analysis include:

1. Medtronic plc
2. Koninklijke Philips N.V.
3. General Electric Company
4. Masimo Corporation
5. ResMed Inc.
6. Becton, Dickinson and Company
7. Chart Industries, Inc.
8. Getinge AB

Competition focuses on product innovation, clinical performance, patient comfort, digital connectivity, regulatory compliance, and distribution capabilities.

A comprehensive company analysis can cover business overviews, key personnel, recent developments, SWOT analysis, and revenue analysis to assess competitive positioning and growth opportunities.

SWOT Analysis of the Europe Respiratory Care Devices Market

Strengths

• Established healthcare infrastructure across major European markets.
• Significant demand for respiratory diagnosis and treatment.
• Strong presence of medical technology companies.

Weaknesses

• High acquisition and maintenance costs for advanced devices.
• Unequal access to diagnostic services across countries.
• Dependence on trained professionals for selected technologies.

Opportunities

• Expansion of home-based respiratory treatment.
• Growth in connected monitoring and digital inhaler technologies.
• Rising demand for sleep apnea diagnosis and treatment.
• Development of portable and patient-friendly equipment.

Threats

• Regulatory and reimbursement complexity.
• Pricing pressures and healthcare budget constraints.
• Supply-chain disruptions and competition from alternative technologies.

Future Outlook: Europe Respiratory Care Devices Market 2026–2034

The European respiratory care devices market is expected to experience sustained growth through 2034. Rising respiratory disease prevalence, demographic aging, and increasing demand for long-term treatment will continue to support equipment adoption.

Digital connectivity, portable respiratory systems, and home healthcare are likely to remain important areas of innovation. At the same time, manufacturers must address affordability, regulatory requirements, and unequal access to diagnosis and treatment.

With the market projected to increase from US$ 6.22 billion in 2025 to US$ 11.88 billion by 2034, companies that combine clinical performance, patient comfort, and accessible technology will be well positioned to benefit from evolving European healthcare needs.

Frequently Asked Questions (FAQs)

1. What is the size of the Europe respiratory care devices market?

The market was valued at US$ 6.22 billion in 2025 and is projected to reach US$ 11.88 billion by 2034.

2. What is the CAGR of the Europe respiratory care devices market?

The market is forecast to grow at a CAGR of 7.45% during 2026–2034.

3. What are the major growth drivers?

Key drivers include the rising prevalence of COPD and asthma, an aging population, technological advancements, increasing home healthcare adoption, and growing awareness of sleep apnea.

4. Which respiratory care devices are widely used in Europe?

Common devices include mechanical ventilators, oxygen concentrators, nebulizers, CPAP and BiPAP machines, pulse oximeters, spirometers, and respiratory monitoring equipment.

5. Which segment dominates the European market?

Therapeutic devices are a major product category, while hospitals represent a leading end-user segment due to critical-care requirements and the need for advanced respiratory support.

6. Which countries are important markets in Europe?

Germany, the United Kingdom, France, Italy, and Spain are important markets, alongside the Netherlands, Belgium, Poland, Norway, Portugal, and other European countries.

7. What are the major challenges facing the market?

High equipment costs, differences in reimbursement policies, underdiagnosis, and limited access to respiratory diagnostic services can constrain market development.

8. What are the key trends shaping the market through 2034?

Major trends include connected respiratory monitoring, portable oxygen therapy, digital inhalers, advanced ventilation systems, home healthcare, and increasing adoption of sleep apnea treatment technologies.

About Renub Research

Renub Research provides market intelligence, industry analysis, and strategic research covering global and regional industries. Its Europe Respiratory Care Devices Market report examines market size, forecasts, growth drivers, restraints, device categories, applications, end users, country-level opportunities, and competitive positioning.

Explore the full report: https://www.renub.com/respiratory-care-devices-market-p.php

SEO Metadata

SEO Title: Europe Respiratory Care Devices Market Size & Forecast 2034

Meta Description: Europe respiratory care devices market to reach US$ 11.88 billion by 2034, growing at a 7.45% CAGR, driven by respiratory diseases and home healthcare.

Suggested URL Slug: europe-respiratory-care-devices-market

Primary Keyword: Europe Respiratory Care Devices Market

Secondary Keywords: Europe respiratory devices market, respiratory care equipment Europe, respiratory care market size, European ventilator market, oxygen concentrators market Europe, CPAP devices Europe, respiratory monitoring devices, home respiratory care Europe.

Suggested H1: Europe Respiratory Care Devices Market Size, Share, Growth, Trends & Forecast 2026–2034

Suggested Image Alt Text: Europe Respiratory Care Devices Market size, growth drivers, medical equipment, and forecast 2026–2034.

Suggested Internal Links: Respiratory Care Devices Market report; related respiratory equipment, ventilator, oxygen concentrator, sleep apnea devices, and medical devices market reports.

Editorial and SEO Publication Notes

Before publishing, verify all market estimates, segment shares, country statistics, and product launch details against their original sources. The supplied market forecast is used as provided and has not been independently audited here. Exclude the unrelated Honeywell urban-safety and Sentrilock real-estate developments from the respiratory care article because they do not establish relevant medical-device market activity.

For stronger AEO, GEO, and AI-search visibility, keep the direct market-size answer near the beginning, use descriptive headings, provide consistent figures and dates, cite authoritative medical and statistical sources, and add appropriate FAQ and Article structured data where supported by the website.